EYPT
EyePoint, Inc.
$13.85
+0.12 (+0.87%)
At close · Jul 15
Market Cap
$1.09B
Shares
83,841,298
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Reginald J. Sanders, M.D. | Director | Appointed | 2026-06-22 |
| Fred Hassan | Director | Appointed | 2026-06-22 |
| Stuart Duty | Director | Appointed | 2026-06-22 |
| Karen Zaderej | Director | Appointed | 2026-06-22 |
| Wendy DiCicco | Director | Appointed | 2026-06-22 |
| John B. Landis, Ph.D. | Director | Appointed | 2026-06-22 |
| Jay S. Duker, M.D. | Director | Appointed | 2026-06-22 |
| Göran Ando, M.D. | Director | Appointed | 2026-06-22 |
Key facts
CIK
1314102
CUSIP
30233G209
13F (30d)
11 filings
10 filers
Visit website
Investor relations